CD Biosynsis provides a specialized platform for the Custom Synthesis of PEG Linkers, catering to the increasingly complex requirements of advanced drug delivery systems like Antibody-Drug Conjugates (ADCs), PROTACs, and Lipid Nanoparticles (LNPs). While catalog PEGs satisfy standard needs, many breakthrough therapies require bespoke linkers with precise chain lengths, specific heterobifunctional handles, or integrated cleavable units. Our synthetic chemistry team excels in the bottom-up construction of monodisperse and polydisperse PEG derivatives, ensuring that your linker is perfectly tailored to your molecule's solubility, stability, and release profile.
Our capabilities span from milligram-scale research batches to kilogram-scale production. We utilize both anionic ring-opening polymerization for high-molecular-weight polymers and stepwise organic synthesis for monodisperse PEG chains where absolute structural purity is paramount. By integrating bioorthogonal chemistry handles—such as Azides, DBCO, and TCO—with traditional reactive groups, we empower researchers to build complex, multi-component bioconjugates with unprecedented ease and efficiency.
Get a QuoteThe core value of a custom PEG linker lies in its ability to act as a multifunctional bridge. Unlike generic spacers, a custom-designed linker can be engineered to include "smart" features. For instance, we can incorporate enzyme-cleavable peptide sequences (like Val-Cit) or pH-sensitive hydrazone bonds directly into the PEG backbone. This allows the PEG to not only improve pharmacokinetics but also facilitate the controlled release of a therapeutic payload at the target site, such as within the acidic environment of a tumor lysosome.
[Image showing the modular construction of a custom heterobifunctional PEG linker with a cleavable unit and bioorthogonal handles]Beyond simple linear structures, our custom synthesis service includes the development of multi-arm, forked, and branched architectures. These are particularly useful for increasing drug loading or creating scaffolding for nanoparticle surface functionalization. Every custom synthesis project is supported by rigorous analytical validation, using high-resolution NMR, HPLC, and Mass Spectrometry to confirm the chemical identity, purity, and polydispersity of the final product, ensuring it meets the stringent specifications required for clinical translation.
Chemical Variety
Synthesis of linkers with combinations of NHS esters, Maleimides, Azides, Alkynes (DBCO/BCN), Tetrazines, and Thiols.
Targeted Delivery
Custom handles allow for sequential, one-pot reactions to link targeting ligands (antibodies) and payloads (toxins/imaging agents).
Precision Purity
Stepwise synthesis of PEGs with an exact number of ethylene glycol units (e.g., PEG-4, PEG-12, PEG-24) to eliminate polydispersity.
Regulatory Edge
Discrete PEGs simplify mass spec analysis of the final conjugate, a significant advantage for characterization and FDA/EMA filings.
Triggered Release
Inclusion of Val-Cit-PAB, Glucuronide, or Disulfide bonds within the PEG chain for environment-specific drug release.
Custom Spacers
Fine-tuning the distance between the cleavage site and the PEG chain to optimize enzyme accessibility and release kinetics.
Our custom synthesis process is designed for transparency and reproducibility, ensuring a seamless transition from lab to pilot scale.
1. Molecular Design
2. Synthetic Execution
3. Advanced Purification
4. Quality Verification
Collaborative design phase where we define the PEG length, architecture, and terminal functional groups based on your conjugation strategy.
Implementation of multi-step organic synthesis or controlled polymerization. In-process monitoring ensures reaction completeness and minimizes byproduct formation.
Comprehensive characterization including 1H NMR for structure, MALDI-TOF or ESI-MS for molecular weight, and analytical HPLC for chemical purity. Polydispersity Index analysis for polymer batches.
Bespoke Architecture
Go beyond the catalog with forked, branched, or multi-functionalized PEGs designed for your specific drug-to-antibody ratio goals.
High Chemical Purity
Industry-leading purification techniques ensure that reactive impurities (like residual catalyst or unfunctionalized chains) are eliminated.
Scalable Solutions
Seamlessly transition from milligram quantities for initial screening to multi-kilogram batches for preclinical and clinical development.
Click Chemistry Expertise
Superior mastery of copper-free and copper-catalyzed click chemistry handles for high-efficiency, site-specific bioconjugation.
1. When should I choose a discrete (monodisperse) PEG over a polydisperse one?
Discrete PEGs (with a single molecular weight) are ideal for ADCs and small-molecule drugs where precise characterization and regulatory consistency are critical. Polydisperse PEGs are typically more cost-effective for large proteins and nanoparticle coatings.
2. Can you synthesize PEGs with multiple different reactive groups?
Yes. We specialize in heterobifunctional and trifunctional PEGs. For example, a linker can have an NHS ester for the protein, an Azide for a drug payload, and a Biotin for imaging or purification.
3. What is the longest discrete PEG chain you can synthesize?
Using stepwise iterative coupling, we can typically synthesize discrete PEGs up to PEG-48 or PEG-64 (approximately 2kDa to 3kDa) while maintaining absolute purity.
4. Do you offer "smart" linkers that respond to specific stimuli?
Absolutely. We can incorporate various triggers including enzyme-cleavable peptides, disulfide bonds for reducing environments, or hydrazones for pH-dependent release.
5. How do you ensure the stability of reactive groups like Maleimide or NHS?
Linkers with moisture-sensitive groups are purified under anhydrous conditions and delivered as lyophilized powders or in dry organic solvents, accompanied by detailed storage instructions.
6. Is it possible to customize the spacer length of the PEG linker?
Yes, we can adjust the chain length by even a single ethylene glycol unit to find the "sweet spot" between therapeutic stability and payload release efficiency.
7. Can you scale up a custom synthesis project for clinical trials?
Yes, our production facilities are designed for scale-up, and we provide comprehensive tech transfer packages and COA documentation to support your clinical path.
8. What information is needed for a custom quote?
Please provide the desired chemical structure (or terminal functional groups), PEG length (or molecular weight), required quantity, and any purity specifications.
Do you have a specific bioconjugation challenge that requires a non-standard PEG architecture or a unique combination of bioorthogonal handles?
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.